STOCK TITAN
  1. Home
  2. Sec-filings
  3. LXEO
  4. [144] Lexeo Therapeutics, Inc. SEC Filing

Lexeo (NASDAQ: LXEO) holder plans stock sale to cover tax bill

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Lexeo Therapeutics, Inc. (LXEO) is the issuer for a planned sale of common stock under Rule 144 by Richard N. Townsend. A brokerage account at Fidelity Brokerage Services LLC indicates 3,345 shares of common stock are intended to be sold, with the securities becoming available through restricted stock vesting dated 08/17/2026. In the prior three months, Townsend reported sales of 3,342 shares on 05/18/2026 and 25,947 shares on 07/01/2026. The notice states that part of the sale proceeds will cover a tax obligation arising from the settlement of a vested equity award distribution.

Positive

  • None.

Negative

  • None.
Planned shares to be sold 3,345 shares Common stock position indicated for sale through Fidelity Brokerage Services LLC
Value of brokerage position 16561.76 Reported value associated with the 3,345 common shares at the broker
Past sale on 05/18/2026 3,342 shares Common stock sold by Richard N. Townsend during the prior three months
Proceeds 05/18/2026 sale 16926.90 Amount associated with the 3,342-share sale on 05/18/2026
Past sale on 07/01/2026 25,947 shares Common stock sold by Richard N. Townsend during the prior three months
Proceeds 07/01/2026 sale 116185.48 Amount associated with the 25,947-share sale on 07/01/2026
Rule 144 regulatory
"See the definition of "person" in paragraph (a) of Rule 144."
Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.
restricted stock vesting financial
"Common | 08/17/2026 | Restricted Stock Vesting | Issuer"
Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.
attorney-in-fact regulatory
"as attorney-in-fact for Richard Townsend"
An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.
equity award distribution financial
"resulting from the settlement of a vested equity award distribution."

FAQ

Who is the selling securityholder in the LXEO Form 144 notice?
The planned Rule 144 sales involve shares held for the account of Richard N. Townsend, with Fidelity Brokerage Services LLC acting as broker. The filing also notes an attorney-in-fact relationship authorizing execution of the notice on Townsend’s behalf.

How many LXEO shares has Richard N. Townsend sold in the last three months?
The filing lists prior sales of 3,342 shares of Lexeo Therapeutics common stock on 05/18/2026 and 25,947 shares on 07/01/2026. These transactions are reported as required aggregation under Rule 144 for the three-month period.

What is the purpose of part of the LXEO share sale mentioned in the Form 144?
The remarks state that the sale includes an amount necessary to cover a tax obligation resulting from settlement of a vested equity award distribution. This indicates that a portion of the shares is being sold in connection with equity compensation taxes.

Through which broker will the planned LXEO Rule 144 sale be executed?
The securities are held at Fidelity Brokerage Services LLC, located at 900 Salem Street, Smithfield, RI 02917. Fidelity is identified in the notice as handling the common stock position and providing the duly authorized representative who signed the filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Source: View Original Filing on SEC EDGAR